InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Discover the complete record of transactions filed by Lee Christopher G, Directeur Scientifique. Officer active across 1 company, notably Apria, Inc.. Aggregated, 13 filings have been recorded. Split: 0 buy · 4 sells. Total volume traded: €140k. History available since 10 August 2021. The latest transaction was disclosed on 10 March 2022 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations13 total
2,261 shares0Common StockSEC:0000899243-22-011317:0
2,700 shares@ US$8.2816.1% of flowCommon StockSEC:0000899243-22-002758
2,700 shares@ US$8.288.1% of flowCommon StockSEC:0000899243-22-002758:0
954 shares@ US$29.2720.3% of flowCommon StockSEC:0000899243-21-048974
954 shares@ US$29.2710.2% of flowCommon StockSEC:0000899243-21-048974:0
2,700 shares@ US$8.2816.2% of flowCommon StockSEC:0000899243-21-048387
2,700 shares@ US$8.288.1% of flowCommon StockSEC:0000899243-21-048387:0
346 shares@ US$4.670.6% of flowCommon StockSEC:0000899243-21-045182:0
346 shares@ US$4.671.2% of flowCommon StockSEC:0000899243-21-045182
1,524 shares@ US$34.6518.7% of flowCommon StockSEC:0000899243-21-041426:0
1,524 shares@ US$34.6537.3% of flowCommon StockSEC:0000899243-21-041426
2,700 shares@ US$4.674.4% of flowCommon StockSEC:0000899243-21-040821:0
2,700 shares@ US$4.678.8% of flowCommon StockSEC:0000899243-21-040821
13 of 13 declarations
About Lee Christopher G
Ruben Tommasi serves as Chief Scientific Officer at Entasis Therapeutics Holdings Inc. In this role, he is responsible for leading the company's research and development activities. Ruben plays a key role in innovation and the development of new therapies to meet patient needs.
